79365162 - EBESANAR

Information

• Trademark
• 79365162

• Source

• Serial Number

  79365162

• Registration Number

  7470205

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  December 07, 2022
  2 years ago

• Registration Date

  August 13, 2024
  6 months ago

• Transaction Date

  February 05, 2025
  8 days ago

• Status Date

  August 13, 2024
  6 months ago

• Published for Opposition Date

  May 28, 2024
  8 months ago

• Location Date

  August 12, 2024
  6 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  CERDA, VICTOR

• Attorney Docket Number

  MREC-7

  Attorney Name

  Sean K. Owens

• Owners

  • RHEACELL GmbH & Co. KG

Case File Statements

• GS0051: Drugs for medical purposes, namely, pharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for treating skin disorders; diagnostic agents, namely, diagnostic radiopharmaceutical agent for use in PET imaging; pharmaceutical preparations, namely, pharmaceutical preparations for treating skin disorders; preparations for medical purposes, namely, pharmaceutical preparations for treating skin disorders; preparations for biomedical purposes, namely, pharmaceutical preparations for treating skin disorders; pharmaceutical cell preparations for treating skin disorders; substances for medical use, namely, pharmaceutical preparations for treating skin disorders; substances for biomedical purposes, namely, pharmaceutical preparations for treating skin disorders; live implants for pharmaceutical purposes, namely, implants comprising living tissue for pharmaceutical purposes; biochemical and chemical products for medical use, namely, pharmaceutical preparations for treating skin disorders; biochemical and chemical products for pharmaceutical purposes, namely, pharmaceutical preparations for treating skin disorders; biochemical and chemical diagnostic preparations for medical purposes; proteins for medical purposes, namely, protein arrays for medical diagnosis purposes; biological preparations for medical and veterinary purposes, namely, pharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparations for external and systemic use, namely, pharmaceutical preparations for treating skin wounds; biological, pharmaceutical and veterinary preparations for skin care for medical purposes, namely, pharmaceutical preparations for treating skin disorders; medical dressings; preparations for wound treating and healing, namely, pharmaceutical preparations for treating skin wounds; pharmaceutical preparations for treating skin wounds; stem cells for medical purposes; stem cells for veterinary purposes; somatic stem cell therapeutics, namely, somatic stem cells for medical or veterinary use; cells for medical use in the nature of fibroblasts for medical purposes; cells for medical use in the nature of fibroblasts for surgical beauty purposes; pharmaceutical implants, namely, implantable pharmaceutical preparations for treating cancer; cells for medical use in the nature of surgical implants derived from stem cells; cells for medical use in the nature of surgical implants derived from fibroblasts; cells for medical use in the nature of biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue, namely, living cells for medical use; biotechnologically engineered tissue products, namely, cells for medical use
• GS0011: Stem cells for scientific use; stem cells for research use; cell growth media for growing cells for scientific use; stem cells other than for medical or veterinary purposes, namely, stem cells for aesthetic purposes excluding all medical or veterinary purposes
• GS0441: Medical services; medical diagnostic testing, monitoring and reporting services; medical assistance; health clinic services; hospital services; plastic and cosmetic surgery; medical therapies, namely, providing laser therapy for treating medical conditions; medical services in the field of regenerative medicine; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells
• GS0421: Pharmaceutical drug development; scientific and technological services, namely, scientific research in the field of genetics; research and development services in the fields of cell diagnostics, cell therapy; scientific research for medical purposes in the field of genetics; stem cell research services; scientific research; scientific research and development; scientific research, testing and analysis services in the field of genetics; medical research; biomedical research services; research and development in the field of biotechnology; research and development in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development of new products; industrial process research, namely, research and development of new products; research and development of new products for the pharmaceutical industry; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information about medical and scientific research for pharmaceutical products; preparation of reports relating to scientific research

Case File Event Statements

• 3/16/2023 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 3/17/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/21/2023 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/13/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/13/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/24/2023 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 4/17/2024 - 10 months ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/14/2023 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 10/24/2023 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 11/13/2023 - a year ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 4/18/2024 - 10 months ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/17/2024 - 10 months ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/18/2024 - 10 months ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/8/2024 - 9 months ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/28/2024 - 8 months ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/28/2024 - 8 months ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/13/2024 - 6 months ago

  18 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 11/13/2024 - 3 months ago

  19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/13/2024 - 6 months ago

  17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/3/2025 - 10 days ago

  20 - FINAL DISPOSITION PROCESSED Type: FIMP

• 2/4/2025 - 9 days ago

  21 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS